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To the Editor: The auditing of health service provision has well-
established benefits, but there is little published on the practical 
monitoring and handling of changes to microbial threats in individual 
hospitals. There is considerable concern about the rise of multidrug-
resistant bacteria, and the roles of healthcare facilities – in particular, 
the lack of adequate infection control procedures – and inappropriate 
broad-spectrum antibiotic use in the genesis and spread of this 
problem. This concern is great in South African hospitals with a 
high proportion of immunocompromised patients at increased risk 
for severe and resistant bacterial infections.1-3 Appropriate empiric 
antibiotic guidelines should be based on accurate and up-to-date 
knowledge of local antibiotic sensitivities. We questioned how many 
hospitals collect, analyse and act on data regarding the prevalence 
and likely provenance of antibiotic resistance in key organisms. The 
National Health Laboratory Service (NHLS) Data Warehouse was 
used to study the trends in blood culture (BC) results at GF Jooste 
Hospital from 2005 to 2010. We investigated the BC contamination 
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Knowledge of local antibiotic sensitivities is crucial to creating 
appropriate empiric antibiotic guidelines. The new National Health 
Laboratory Service (NHLS) Data Warehouse allows clinicians to 
access collated spreadsheets of culture isolates and antimicrobial 
susceptibility patterns for their facilities. We used this service to 
study the trends in blood culture (BC) results at GF Jooste Hospital 
from 2005 to 2010. We investigated the BC contamination rate and 
changes in the antibiotic sensitivity profiles of selected organisms, 
and estimated the proportion of infections that were hospital-
acquired. Over 3000 BCs were performed per year in this period. 
A very high contamination rate was observed (7 - 9%) in 2005 - 
2007, with a gratifying reduction by 2010. Ceftriaxone resistance 
increased from 16% to 62% in Klebsiella pneumoniae (p<0.0001), 
and from 33% to 100% in Enterobacter spp. (p=0.053).
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Table 1. Results of blood cultures (BCs) performed  
according to year (2005 - 2010)
Year
Total 
BCs
(N)
Positive-
growth 
BCs 
(N (%))
CNS 
growth on 
BC 
(N (%))
Non-CNS 
growth on 
BC 
(N)
Total CNS 
growth on 
positive-
growth 
BCs (%)
2005 3 988 872 (21.9) 323 (8.1) 549 37.0
2006 2 842 493 (17.3) 202 (7.1) 291 41.0
2007 3 081 712 (23.1) 288 (9.3) 424 40.4
2008 3 341 615 (18.4) 254 (7.6) 361 41.3
2009 3 242 531 (16.4) 237 (7.3) 294 44.6
2010 3 143 421 (13.4) 145 (4.6) 276 34.4
p<0.0000* p<0.0000* p<0.0000* p=0.638*
*Chi-square test for trend.
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rate and changes in the antibiotic sensitivity of selected organisms, 
and estimated the proportion of hospital-acquired infections.
Methods
The major indications for BCs at GF Jooste are patients who 
present with pneumonia, unexplained fever – particularly in the 
immunocompromised – and in patients with suspected nosocomial 
sepsis. All specimens were processed at the NHLS Greenpoint 
laboratory. Isolation, identification and sensitivity testing was 
performed according to standard methods and the Clinical and 
Laboratory Standards Institute (CLSI) guidelines.4 Sensitivity testing 
was performed manually or with the Vitek 2 system. Changes in 
resistance trends over time were assessed with chi-squared tests using 
Stata 10. The study was approved by the Research Ethics Committee 
of the University of Cape Town.
Results
Over 3000 BCs were performed per year; 66% were performed 
in casualty and 18% in the 2 medical wards. The remainder were 
performed in the 2 surgical wards, high care unit and outpatients 
departments (Table 1). Although the number of BCs performed 
per year changed marginally between 2005 and 2010, there was a 
statistically significant decline in the number of BCs with positive 
growth (from 872 to 421, p<0.0000) and a decline in BCs positive for 
a coagulase-negative Staphylococcus (CNS) (323 to 145, p<0.0000). In 
2005 - 2007, an alarming 7 - 9% of all BCs and 40% of all positive-
growth BCs were positive for a CNS. About 97% of these were likely 
skin contaminants due to poor aseptic technique.4 The contamination 
rate was therefore 3 times higher than the internationally accepted 
rate of 3%.5 A statistically significant and gratifying reduction to 4.6% 
was observed in 2010. 
Over the 5-year period, there was also a decline in positive-growth 
BCs (22 - 13%), including a decline in the numbers of CNS and 
non-CNS organisms. This might have been attributed to a decline 
in admissions due to changes to the hospital referral area and a 
simultaneous increase in the rate of BCs performed per admission. 
The initial high BC positivity rate might have been, in part, related 
to excess workload and attributable to too few BCs being performed.
The decline in the contamination rate could also have been related 
to a reduced workload, but was more likely the result of a campaign 
focused on proper BC technique education and improved infection 
control with an increased supply of chlorhexidine-alcohol cleaning 
solution. 
Klebsiella pneumoniae (KP) and the Enterobacter species 
demonstrated the most concerning increase in resistance (Fig. 
1). The chi-squared test for trend revealed a highly significant 
increase in ceftriaxone resistance in KP between 2005 and 2010 
(16 - 62%, p<0.0001) and a borderline increase in Enterobacter 
spp. (33 - 100%, p=0.053). Ceftriaxone resistance in E. coli 
remained relatively low (5 - 13%, p=0.089). The monitoring of 
ceftriaxone resistance is particularly important as it can reflect 
the acquisition of extended spectrum beta-lactamases (ESBLs). It 
is likely that at least 5 of the 9 ESBL-producing KP infections in 
2009 were hospital-acquired, as the corresponding BCs first came 
up positive 9 - 21 days after admission. In 2009, 3 and 6 of the 
9 ESBL-producing KP infections were intermediately and fully 
sensitive to amikacin, respectively.
There was no increase in cloxacillin resistance in Staphylococcus 
aureus, but at least 3 of the 7 MRSA BC isolates from 2009 were 
considered to be hospital-acquired (the time from admission 
to first positive BC was 11 - 37 days). Most MRSAs remained 
sensitive to clindamycin. Overall clindamycin resistance was 
low (7% average over 6 years); this is considerably lower than in 
neighbouring tertiary hospitals.6 Organisms from the 8-bedded 
high and intensive care unit revealed no MRSA isolates; all ESBL-
producing organisms were sensitive to amikacin.
Discussion
From this simple and fast audit we concluded that: (i) the 
contamination rate, though reduced, was unacceptably high; (ii) 
there was a rising rate of ESBL-producing KP infection, most of 
which was nosocomially acquired and some of which was likely 
to have been driven by the widespread use of ceftriaxone; and 
(iii) the high proportion of hospital-acquired MRSA and ESBL-
producing KP suggested a failure of basic infection control. 
We presented these findings to each hospital department to 
motivate behavioural change in 3 domains. Firstly, with emphasis 
on the casualty department where most BCs were performed, 
we encouraged doctors to comply with our simple and clear 
guidelines printed on the BC trays. Secondly, we motivated 
for improved antibiotic stewardship. Thirdly, we reiterated the 
under-practised key points of infection control that facilitated 
the spread of resistant organisms, especially hand-washing before 
and after patient contact. Furthermore, bottlenecks in the supply 
of sufficient quantities of chlorhexidine to various wards were 
identified and addressed.
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Fig. 1. Ceftriaxone resistance in Klebsiella pneumoniae (KP).
